✦ LIBER ✦

Hyperimmuneglobulin for cytomegalovirus prophylaxis following heart transplantation

✍ Scribed by Schäfers, H.-J.; Wahlers, Th.; Jurmann, M.; Fieguth, H.-G.; Milbradt, H.; Flik, J.; Haverich, A.

Book ID: 122086151
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 347 KB
Volume: 12
Category: Article
ISSN: 0195-6701
DOI: 10.1016/0195-6701(88)90031-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytomegalovirus infection prophylaxis fo

Cytomegalovirus infection prophylaxis following heart transplantation: comparison of two regimes

✍ H. Antretter; D. Hoefer; H. Hangler; J. Margreiter; C. Larcher; R. Margreiter; G 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 81 KB

2. Prophylaxis for Cytomegalovirus infec

2. Prophylaxis for Cytomegalovirus infection in patients following renal transplantation

📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Low-Dose Valganciclovir for Cytomegalovi

Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Heart Transplant Recipients

✍ Julian, K.G.; Shattahi, E.; Burg, J.E.; Boehmer, J.P. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Intravenous ganciclovir prophylaxis for

Intravenous ganciclovir prophylaxis for cytomegalovirus in heart, heart-lung, and lung transplant recipients

✍ T.G. Wreghitt; S.J.C. Abel; K. McNeil; J. Parameshwar; L. Sharpies; S. Large; J. 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 594 KB

Intravenous ganciclovir prophylaxis for

Intravenous ganciclovir prophylaxis for cytomegalovirus in heart, heart-lung, and lung transplant recipients

✍ T. G. Wreghitt; Simon J. C. Abel; Keith McNeil; Jayan Parameshwar; Susan Stewart 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 64 KB

Impact of cytomegalovirus prophylaxis on

Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation

✍ Michelle Slifkin; Robin Ruthazer; Richard Freeman; Judy Bloom; Susan Fitzmaurice 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

With improved cytomegalovirus (CMV) prophylaxis, CMV disease after liver transplantation has decreased dramatically, and patient and graft survival have improved. We examined the impact of CMV prophylaxis on biopsy proven rejection after orthotopic liver transplantation by analyzing data on 192 live